Trials / Unknown
UnknownNCT05839977
The Effect of Telerehabilitation on Balance in People With Multiple Sclerosis
Possibilities of Using Telerehabilitation for the Therapy of Balance and Walking Disorders in Patients With Multiple Sclerosis in Clinical Practice
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Charles University, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study will compare the effect of individual telerehabilitation with offline remote exercise through videos and with a control group without intervention. The monitored group will be people with multiple sclerosis with balance impairment. The duration of the intervention will be 12 weeks.
Detailed description
Total of 60 persons will be randomly divided into two experimental and one control groups. After dividing into individual groups, all probands will be examined using objective and subjective tests for balance and walking. The same testing will be done after the end of the 12-week intervention. The group with individual telerehabilitation will exercise twice a week. The exercise will consist of strength and balance exercises using the Homebalance ® system. For direct synchronous contact between the physiotherapist and the patient, an audiovisual link via the freely available ZOOM app was used. The second experimental group will receive 12 video recordings of exercises created by a physiotherapist for home exercises, according to which they will also exercise twice a week. The control group receives no intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Individual telerehabilitation | The exercise will consist of strength and balance exercises using the Homebalance ® system |
| OTHER | Home exercises based on videos | intervention include 12 video recordings of exercises created by a physiotherapist for home exercises, according to which they will also exercise |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2025-10-01
- Completion
- 2025-12-01
- First posted
- 2023-05-03
- Last updated
- 2023-05-03
Locations
2 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT05839977. Inclusion in this directory is not an endorsement.